Calidi Biotherapeutics Inc (CLDI)’s stock has witnessed a price declined of -22.71% from the previous close with its current price standing at $0.59. Its current price is -84.90% under its 52-week high of $3.89 and 189.79% more than its 52-week low of $0.20. Based on the past 30-day period, the stock price is -62.21% below the high and +198.27% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CLDI’s SMA-200 is $0.9617.
CLDI’s price to book ratio for the most recent quarter was 2.69, resulting in an 1.90 price to cash per share for the period.
How does Calidi Biotherapeutics Inc (CLDI) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Calidi Biotherapeutics Inc (AMEX: CLDI) Ownership Details
I will give a breakdown of the key shareholders in Calidi Biotherapeutics Inc (CLDI). Recent figures show that the company’s insiders hold 6.81% of shares. A total of 39 institutional investors hold shares in the company, making 17.25% of its stock and 18.50% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Armistice Capital, LLC holding total of 3.32 shares that make 9.15% of the company’s total number of shares and are currently priced at 1.84 million.
The securities firm Bank of Montreal /CAN/ holds 489.8 shares of CLDI, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.35% , and the holding percentage of shares is valued at 0.27 million.
An overview of Calidi Biotherapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Calidi Biotherapeutics Inc (CLDI) traded 41,697,047 shares per day, with a moving average of $0.3678 and price change of +0.2612. With the moving average of $0.3880 and a price change of +0.1221, about 16,927,189 shares changed hands on average over the past 50 days. Finally, CLDI’s 100-day average volume is 8,701,679 shares, alongside a moving average of $0.5353 and a price change of -0.6854.
